Impax Laboratories Profile

Impax Laboratories Patent Grants

Controlled release formulations of levodopa and uses thereof

Patent Number 9533046 - January 3, 2017

The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a…

Controlled release formulations of levodopa and uses thereof

Patent Number 9463246 - October 11, 2016

The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a…

Controlled release formulations of levodopa and uses thereof

Patent Number 9089607 - July 28, 2015

The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a…

Controlled release formulations of levodopa and uses thereof

Patent Number 9089608 - July 28, 2015

The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a…

Controlled release formulations of levodopa and uses thereof

Patent Number 8557283 - October 15, 2013

The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a…

Impax Laboratories Patent Applications

CONTROLLED RELEASE FORMULATIONS OF LEVODOPA AND USES THEREOF

Application Number 20120177731 - July 12, 2012

The current invention provides a controlled release oral solid formulation of levodopa comprising levodopa, a decarboxylase inhibitor, and a…

Oral disintegrating dosage forms

Application Number 20050147670 - July 7, 2005

The invention is directed to pharmaceutical dosage forms having immediate release via rapid oral disintegration, specifically, orally…

Impax Laboratories Federal District Court Decisions

LEJON-TWIN EL v. MARINO et al

New Jersey District Court - August 7, 2017

OPINION. Signed by Judge Kevin McNulty on 8/7/2017. (ld, )

PLUMBERS' LOCAL UNION NO. 690 HEALTH PLAN v. ACTAVIS INC. et al

Pennsylvania Eastern District Court - July 24, 2017

ORDER of MEMORANDUM AND/OR OPINION (ECF 321) 1. DEFENDANT APOTEX CORP'S INDIVIDUAL MOTION TO DISMISS (ECF NO. 193) IS GRANTED AS TO…

PLUMBERS' LOCAL UNION NO. 690 HEALTH PLAN v. ACTAVIS INC. et al

Pennsylvania Eastern District Court - July 24, 2017

MEMORANDUM AND/OR OPINION. SIGNED BY HONORABLE ANITA B. BRODY ON 7/24/2017. 7/24/2017 ENTERED AND COPIES VIA ECF.(mo, )

Family Medicine Pharmacy, LLC v. Impax Laboratories, Inc.

Alabama Southern District Court - May 23, 2017

ORDER denying without prejudice 31 Motion to Enjoin Copycat Class Action. Signed by District Judge William H. Steele on 5/23/2017. (tgw)

IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. et al

New Jersey District Court - May 9, 2017

OPINION/ORDER re: construction of claims in U.S. Patent No. 8,377,474 (the 474 patent). Signed by Judge Stanley R. Chesler on 5/9/17. (DD, )

Impax Laboratories State Court Decisions

IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. et al

New Jersey New Jersey District Court - May 9, 2017

OPINION/ORDER re: construction of claims in U.S. Patent No. 8,377,474 (the 474 patent). Signed by Judge Stanley R. Chesler on 5/9/17. (DD, )

Impax Laboratories Inc. et al v. Lannett Holdings Inc. et al

Delaware Delaware District Court - March 29, 2017

TRIAL OPINION. Defendants have failed to prove the Dearn patents are invalid. If desired, Defendants should request an opportunity to…

Impax Laboratories, Inc. v. Turing Pharmaceuticals AG

New York New York Southern District Court - November 16, 2016

OPINION AND ORDER. For the foregoing reasons, Defendant's motion to dismiss with prejudice Plaintiff's unjust enrichment claim…

ENDO PHARMACEUTICALS INC. v. IMPAX LABORATORIES, INC.

New Jersey New Jersey District Court - October 25, 2016

OPINION. Signed by Judge Jose L. Linares on 10/25/16. (DD, )

IMPAX LABORATORIES, INC. v. ACTAVIS LABORATORIES FL, INC. et al

New Jersey New Jersey District Court - May 27, 2016

OPINION/ORDER granting in part and denying in part 43 Motion to Stay; that Impax shall provide the Court with status updates regarding the ex…